Igor Matushansky Insider Profile
4 Followers
Igor Matushansky, CMO at Immuneering, holds ― shares in Immuneering (Ticker: IMRX), holds ― shares in Supernus Pharmaceuticals (Ticker: ~SUPN), holds 100.24K shares in Hookipa Pharma (Ticker: HOOK).
Igor Matushansky's Trading History
| HOOKHookipa Pharma | Feb 01, 2022 | ― | Uninformative Buy | 44.80K | $115.28K | |
| ~SUPNSupernus Pharmaceuticals | ― | ― | ― | ― | ||
| IMRXImmuneering | ― | CMO | ― | ― |
You May Also Like
Igor Matushansky insider profile FAQ
What is the percentage of profitable transactions made by Igor Matushansky?
The percentage of profitable transactions made by Igor Matushansky is 33%.
What is the average return per transaction made by Igor Matushansky?
The average return per transaction made by Igor Matushansky is -3.80%.
What stocks does Igor Matushansky hold?
Igor Matushansky holds: IMRX, ~SUPN, HOOK stocks.
What was Igor Matushansky's most profitable transaction?
Igor Matushansky’s most profitable transaction was an Informative Sell of HOOK stock on January 31, 2020. The return on the trade was 10.90%.
What is Igor Matushansky's role in Immuneering?
Igor Matushansky's role in Immuneering is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
